| 1A9U | A: | THE COMPLEX STRUCTURE OF THE MAP KINASE P38/SB203580 |
| 1BL6 | A: | THE COMPLEX STRUCTURE OF THE MAP KINASE P38/SB216995 |
| 1BL7 | A: | THE COMPLEX STRUCTURE OF THE MAP KINASE P38/SB220025 |
| 1BMK | A: | THE COMPLEX STRUCTURE OF THE MAP KINASE P38/SB218655 |
| 1DI9 | A: | THE STRUCTURE OF P38 MITOGEN-ACTIVATED PROTEIN KINASE IN COMPLEX WITH 4-[3-METHYLSULFANYLANILINO]-6,7-DIMETHOXYQUINAZOLINE |
| 1IAN | A: | HUMAN P38 MAP KINASE INHIBITOR COMPLEX |
| 1KV1 | A: | P38 MAP KINASE IN COMPLEX WITH INHIBITOR 1 |
| 1KV2 | A: | HUMAN P38 MAP KINASE IN COMPLEX WITH BIRB 796 |
| 1M7Q | A: | CRYSTAL STRUCTURE OF P38 MAP KINASE IN COMPLEX WITH A DIHYDROQUINAZOLINONE INHIBITOR |
| 1OUK | A: | THE STRUCTURE OF P38 ALPHA IN COMPLEX WITH A PYRIDINYLIMIDAZOLE INHIBITOR |
| 1OUY | A: | THE STRUCTURE OF P38 ALPHA IN COMPLEX WITH A DIHYDROPYRIDO-PYRIMIDINE INHIBITOR |
| 1OVE | A: | THE STRUCTURE OF P38 ALPHA IN COMPLEX WITH A DIHYDROQUINOLINONE |
| 1OZ1 | A: | P38 MITOGEN-ACTIVATED KINASE IN COMPLEX WITH 4-AZAINDOLE INHIBITOR |
| 1R39 | A: | THE STRUCTURE OF P38ALPHA |
| 1R3C | A: | THE STRUCTURE OF P38ALPHA C162S MUTANT |
| 1WFC | A: | STRUCTURE OF APO, UNPHOSPHORYLATED, P38 MITOGEN ACTIVATED PROTEIN KINASE P38 (P38 MAP KINASE) THE MAMMALIAN HOMOLOGUE OF THE YEAST HOG1 PROTEIN |
| 1YQJ | A: | CRYSTAL STRUCTURE OF P38 ALPHA IN COMPLEX WITH A SELECTIVE PYRIDAZINE INHIBITOR |
| 1ZYJ | A: | HUMAN P38 MAP KINASE IN COMPLEX WITH INHIBITOR 1A |
| 1ZZ2 | A: | TWO CLASSES OF P38ALPHA MAP KINASE INHIBITORS HAVING A COMMON DIPHENYLETHER CORE BUT EXHIBITING DIVERGENT BINDING MODES |
| 1ZZL | A: | CRYSTAL STRUCTURE OF P38 WITH TRIAZOLOPYRIDINE |
| 2BAJ | A: | P38ALPHA BOUND TO PYRAZOLOUREA |
| 2BAK | A: | P38ALPHA MAP KINASE BOUND TO MPAQ |
| 2BAL | A: | P38ALPHA MAP KINASE BOUND TO PYRAZOLOAMINE |
| 2BAQ | A: | P38ALPHA BOUND TO RO3201195 |
| 2GFS | A: | P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH RO3201195 |
| 2I0H | A: | THE STRUCTURE OF P38ALPHA IN COMPLEX WITH AN ARYLPYRIDAZINONE |
| 2LGC | A: | JOINT NMR AND X-RAY REFINEMENT REVEALS THE STRUCTURE OF A NOVEL DIBENZO[A,D]CYCLOHEPTENONE INHIBITOR/P38 MAP KINASE COMPLEX IN SOLUTION |
| 2OKR | A:; D: | CRYSTAL STRUCTURE OF THE P38A-MAPKAP KINASE 2 HETERODIMER |
| 2ONL | A:4-352; B:4-352 | CRYSTAL STRUCTURE OF THE P38A-MAPKAP KINASE 2 HETERODIMER |
| 2QD9 | A: | P38 ALPHA MAP KINASE INHIBITOR BASED ON HETEROBICYCLIC SCAFFOLDS |
| 2RG5 | A: | PHENYLALANINE PYRROLOTRIAZINE P38 ALPHA MAP KINASE INHIBITOR COMPOUND 11B |
| 2RG6 | A: | PHENYLALANINE PYRROLOTRIAZINE P38 ALPHA MAP KINASE INHIBITOR COMPOUND 11J |
| 3BV2 | A: | MORPHOLINO PYRROLOTRIAZINE P38 ALPHA MAP KINASE INHIBITOR COMPOUND 30 |
| 3BV3 | A: | MORPHOLINO PYRROLOTRIAZINE P38 ALPHA MAP KINASE INHIBITOR COMPOUND 2 |
| 3BX5 | A: | P38 ALPHA MAP KINASE COMPLEXED WITH BMS-640994 |
| 3C5U | A: | P38 ALPHA MAP KINASE COMPLEXED WITH A BENZOTHIAZOLE BASED INHIBITOR |
| 3CTQ | A: | STRUCTURE OF MAP KINASE P38 IN COMPLEX WITH A 1-O-TOLYL-1,2, 3-TRIAZOLE-4-CARBOXAMIDE |
| 3D7Z | A: | CRYSTAL STRUCTURE OF P38 KINASE IN COMPLEX WITH A BIPHENYL AMIDE INHIBITOR |
| 3D83 | A: | CRYSTAL STRUCTURE OF P38 KINASE IN COMPLEX WITH A BIPHENYL AMIDE INHIBITOR |
| 3DS6 | A:; B:; C:; D: | P38 COMPLEX WITH A PHTHALAZINE INHIBITOR |
| 3DT1 | A: | P38 COMPLEXED WITH A QUINAZOLINE INHIBITOR |
| 3FC1 | X: | CRYSTAL STRUCTURE OF P38 KINASE BOUND TO PYRIMIDO-PYRIDAZINONE INHIBITOR |
| 3FI4 | A: | P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH RO4499 |
| 3FKL | A: | P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH RO9552 |
| 3FKN | A: | P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH RO7125 |
| 3FKO | A: | P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH RO3668 |
| 3FL4 | A: | P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH RO5634 |
| 3FLN | C: | P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH R1487 |
| 3FLQ | A: | P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH 6-(2,4-DIFLUORO-PHENOXY)-2-((S)-2-METHANESULFONYL-1-METHYL-ETHYLAMINO)-8-METHYL-8H-PYRIDO[2,3-D]PYRIMIDIN |
| 3FLS | A: | P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH 6-(2,4-DIFLUORO-PHENOXY)-2-((R)-2-METHANESULFONYL-1-METHYL-ETHYLAMINO)-8-METHYL-8H-PYRIDO[2,3-D]PYRIMIDIN-7-ONE |
| 3FLW | A: | P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH PAMAPIMOD |
| 3FLY | A: | P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH 6-(2,4-DIFLUORO-PHENOXY)-2-ISOPROPYLAMINO-8-METHYL-8H-PYRIDO[2,3-D]PYRIMIDIN-7-ONE |
| 3FLZ | A: | P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH 8-METHYL-6-PHENOXY-2-(TETRAHYDRO-PYRAN-4-YLAMINO)-8H-PYRIDO[2,3-D]PYRIMIDIN-7-ONE |
| 3FMH | A: | P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH 6-(2,4-DIFLUORO-PHENOXY)-8-METHYL-2-((R)-1-METHYL-2-TETRAZOL-2-YL-ETHYLAMINO)-8H-PYRIDO[2,3-D]PYRIMIDIN-7-ONE |
| 3FMJ | A: | P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH 4-(5-METHYL-3-PHENYL-ISOXAZOL-4-YL)-PYRIMIDIN-2-YLAMINE |
| 3FMK | A: | P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH 6-(2,4-DIFLUORO-PHENOXY)-8-METHYL-2-((S)-1-METHYL-2-TETRAZOL-2-YL-ETHYLAMINO)-8H-PYRIDO[2,3-D]PYRIMIDIN-7-ONE |
| 3FML | A: | P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH RO6224 |
| 3FMM | A: | P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH RO6226 |
| 3FMN | A: | P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH RO2530 |
| 3FSF | A: | P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH 3-(2,6-DICHLORO-PHENYL)-7-[4-(2-DIETHYLAMINO-ETHOXY)-PHENYLAMINO]-1-METHYL-3,4-DIHYDRO-1H-PYRIMIDO[4,5-D]PYRIMIDIN-2-ONE |
| 3FSK | A: | P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH RO6257 |
| 3GCP | A: | HUMAN P38 MAP KINASE IN COMPLEX WITH SB203580 |
| 3GCQ | A: | HUMAN P38 MAP KINASE IN COMPLEX WITH RL45 |
| 3GCS | A: | HUMAN P38 MAP KINASE IN COMPLEX WITH SORAFENIB |
| 3GCU | A:; B: | HUMAN P38 MAP KINASE IN COMPLEX WITH RL48 |
| 3GCV | A: | HUMAN P38 MAP KINASE IN COMPLEX WITH RL62 |
| 3GFE | A: | CRYSTAL STRUCTURE OF P38A MITOGEN-ACTIVATED PROTEIN KINASE IN COMPLEX WITH A PYRAZOLOPYRIDINONE INHIBITOR |
| 3GI3 | A: | CRYSTAL STRUCTURE OF A N-PHENYL-N'-NAPHTHYLUREA ANALOG IN COMPLEX WITH P38 MAP KINASE |
| 3HA8 | A: | THE COMPLEX STRUCTURE OF THE MAP KINASE P38/COMPOUND 14B |
| 3HEC | A: | P38 IN COMPLEX WITH IMATINIB |
| 3HEG | A: | P38 IN COMPLEX WITH SORAFENIB |
| 3HRB | A: | P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH SMALL MOLECULE INHIBITOR |
| 3HUB | A: | HUMAN P38 MAP KINASE IN COMPLEX WITH SCIOS-469 |
| 3HUC | A: | HUMAN P38 MAP KINASE IN COMPLEX WITH RL40 |
| 3HV3 | A: | HUMAN P38 MAP KINASE IN COMPLEX WITH RL49 |
| 3HV4 | A:; B: | HUMAN P38 MAP KINASE IN COMPLEX WITH RL51 |
| 3HV5 | A:; B: | HUMAN P38 MAP KINASE IN COMPLEX WITH RL24 |
| 3HV6 | A: | HUMAN P38 MAP KINASE IN COMPLEX WITH RL39 |
| 3HV7 | A: | HUMAN P38 MAP KINASE IN COMPLEX WITH RL38 |
| 3HVC | A: | CRYSTAL STRUCTURE OF HUMAN P38ALPHA MAP KINASE |
| 3IPH | A: | CRYSTAL STRUCTURE OF P38 IN COMPLEX WITH A BIPHENYLAMIDE INHIBITOR |
| 3ITZ | A: | CRYSTAL STRUCTURE OF P38A MITOGEN-ACTIVATED PROTEIN KINASE IN COMPLEX WITH A PYRAZOLOPYRIDAZINE INHIBITOR |
| 3IW5 | A: | HUMAN P38 MAP KINASE IN COMPLEX WITH AN INDOLE DERIVATIVE |
| 3IW6 | A: | HUMAN P38 MAP KINASE IN COMPLEX WITH A BENZYLPIPERAZIN-PYRROL |
| 3IW7 | A: | HUMAN P38 MAP KINASE IN COMPLEX WITH AN IMIDAZO-PYRIDINE |
| 3IW8 | A: | STRUCTURE OF INACTIVE HUMAN P38 MAP KINASE IN COMPLEX WITH A THIAZOLE-UREA |
| 3K3I | A: | P38ALPHA BOUND TO NOVEL DGF-OUT COMPOUND PF-00215955 |
| 3K3J | A: | P38ALPHA BOUND TO NOVEL DFG-OUT COMPOUND PF-00416121 |
| 3KQ7 | A: | STRUCTURE OF HUMAN P38ALPHA WITH N-[4-METHYL-3-(6-{[2-(1-METHYLPYRROLIDIN-2-YL)ETHYL]AMINO}PYRIDINE-3-AMIDO)PHENYL]-2-(MORPHOLIN-4-YL)PYRIDINE-4-CARBOXAMIDE |
| 3L8S | A: | HUMAN P38 MAP KINASE IN COMPLEX WITH CP-547632 |
| 3L8X | A: | P38 ALPHA KINASE COMPLEXED WITH A PYRAZOLO-PYRIMIDINE BASED INHIBITOR |
| 3LFA | A: | HUMAN P38 MAP KINASE IN COMPLEX WITH DASATINIB |
| 3LFB | A: | HUMAN P38 MAP KINASE IN COMPLEX WITH RL98 |
| 3LFC | A: | HUMAN P38 MAP KINASE IN COMPLEX WITH RL99 |
| 3LFE | A: | HUMAN P38 MAP KINASE IN COMPLEX WITH RL116 |
| 3LFF | A: | HUMAN P38 MAP KINASE IN COMPLEX WITH RL166 |
| 3MGY | A: | MUTAGENESIS OF P38 MAP KINASE ESHTABLISHES KEY ROLES OF PHE169 IN FUNCTION AND STRUCTURAL DYNAMICS AND REVEALS A NOVEL DFG-OUT STATE |
| 3MH0 | A: | MUTAGENESIS OF P38 MAP KINASE ESHTABLISHES KEY ROLES OF PHE169 IN FUNCTION AND STRUCTURAL DYNAMICS AND REVEALS A NOVEL DFG-OUT STATE |
| 3MH1 | A: | MUTAGENESIS OF P38 MAP KINASE ESTABLISHES KEY ROLES OF PHE169 IN FUNCTION AND STRUCTURAL DYNAMICS AND REVEALS A NOVEL DFG-OUT STATE |
| 3MH2 | A: | MUTAGENESIS OF P38 MAP KINASE ESTABLISHES KEY ROLES OF PHE169 IN FUNCTION AND STRUCTURAL DYNAMICS AND REVEALS A NOVEL DFG-OUT STATE |
| 3MH3 | A: | MUTAGENESIS OF P38 MAP KINASE ESTABLISHES KEY ROLES OF PHE169 IN FUNCTION AND STRUCTURAL DYNAMICS AND REVEALS A NOVEL DFG-OUT STATE |
| 3MPA | A: | CONFORMATIONAL PLASTICITY OF P38 MAP KINASE DFG MOTIF MUTANTS IN RESPONSE TO INHIBITOR BINDING |
| 3MPT | A: | CRYSTAL STRUCTURE OF P38 KINASE IN COMPLEX WITH A PYRROLE-2-CARBOXAMIDE INHIBITOR |
| 3MVL | A:; B: | P38 ALPHA MAP KINASE COMPLEXED WITH PYRROLOTRIAZINE INHIBITOR 7K |
| 3MVM | A:; B: | P38 ALPHA MAP KINASE COMPLEXED WITH PYRROLOTRIAZINE INHIBITOR 7V |
| 3MW1 | A: | P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH SMALL MOLECULE INHIBITOR |
| 3NEW | A: | P38-ALPHA COMPLEXED WITH COMPOUND 10 |
| 3NNU | A: | CRYSTAL STRUCTURE OF P38 ALPHA IN COMPLEX WITH DP1376 |
| 3NNV | A: | CRYSTAL STRUCTURE OF P38 ALPHA IN COMPLEX WITH DP437 |
| 3NNW | A: | CRYSTAL STRUCTURE OF P38 ALPHA IN COMPLEX WITH DP802 |
| 3NNX | A: | CRYSTAL STRUCTURE OF PHOSPHORYLATED P38 ALPHA IN COMPLEX WITH DP802 |
| 3NWW | A: | P38 ALPHA KINASE COMPLEXED WITH A 2-AMINOTHIAZOL-5-YL-PYRIMIDINE BASED INHIBITOR |
| 3O8P | A: | CONFORMATIONAL PLASTICITY OF P38 MAP KINASE DFG MOTIF MUTANTS IN RESPONSE TO INHIBITOR BINDING |
| 3O8T | A: | CONFORMATIONAL PLASTICITY OF P38 MAP KINASE DFG-MOTIF MUTANTS IN RESPONSE TO INHIBITOR BINDING |
| 3O8U | A: | CONFORMATIONAL PLASTICITY OF P38 MAP KINASE DFG MOTIF MUTANTS IN RESPONSE TO INHIBITOR BINDING |
| 3OBG | A: | CONFORMATIONAL PLASTICITY OF P38 MAP KINASE DFG MUTANTS IN RESPONSE TO INHIBITOR BINDING |
| 3OBJ | A: | CONFORMATIONAL PLASTICITY OF P38 MAP KINASE DFG MUTANTS IN RESPONSE TO INHIBITOR BINDING |
| 3OC1 | A: | CONFORMATIONAL PLASTICITY OF P38 MAP KINASE DFG MOTIF MUTANTS IN RESPONSE TO INHIBITOR BINDING |
| 3OCG | A: | P38 ALPHA KINASE COMPLEXED WITH A 5-AMINO-PYRAZOLE BASED INHIBITOR |
| 3OD6 | X: | CRYSTAL STRUCTURE OF P38ALPHA Y323T ACTIVE MUTANT |
| 3ODY | X: | CRYSTAL STRUCTURE OF P38ALPHA Y323Q ACTIVE MUTANT |
| 3ODZ | X: | CRYSTAL STRUCTURE OF P38ALPHA Y323R ACTIVE MUTANT |
| 3OEF | X: | CRYSTAL STRUCTURE OF Y323F INACTIVE MUTANT OF P38ALPHA MAP KINASE |
| 3PG3 | A: | HUMAN P38 MAP KINASE IN COMPLEX WITH RL182 |
| 3QUD | A: | HUMAN P38 MAP KINASE IN COMPLEX WITH 2-AMINO-PHENYLAMINO-BENZOPHENONE |
| 3QUE | A: | HUMAN P38 MAP KINASE IN COMPLEX WITH SKEPINONE-L |
| 3RIN | A: | P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH SMALL MOLECULE INHIBITOR |
| 3S3I | A: | P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH SMALL MOLECULE INHIBITOR |
| 3S4Q | A: | P38 ALPHA KINASE COMPLEXED WITH A PYRAZOLO-TRIAZINE BASED INHIBITOR |
| 3U8W | A: | CRYSTAL STRUCTURE OF P38A MITOGEN-ACTIVATED PROTEIN KINASE IN COMPLEX WITH A TRIAZOLOPYRIDAZINONE INHIBITOR |
| 3UVP | A: | HUMAN P38 MAP KINASE IN COMPLEX WITH A BENZAMIDE SUBSTITUTED BENZOSUBERONE |
| 3UVQ | A: | HUMAN P38 MAP KINASE IN COMPLEX WITH A DIBENZOSUBERONE DERIVATIVE |
| 3UVR | A: | HUMAN P38 MAP KINASE IN COMPLEX WITH KM064 |
| 4A9Y | A: | P38ALPHA MAP KINASE BOUND TO CMPD 8 |
| 4AA4 | A: | P38ALPHA MAP KINASE BOUND TO CMPD 22 |
| 4AA5 | A: | P38ALPHA MAP KINASE BOUND TO CMPD 33 |
| 4AAC | A: | P38ALPHA MAP KINASE BOUND TO CMPD 29 |
| 4DLI | A: | HUMAN P38 MAP KINASE IN COMPLEX WITH RL87 |
| 4DLJ | A: | HUMAN P38 MAP KINASE IN COMPLEX WITH RL163 |
| 4E5A | X: | THE W197A MUTANT OF P38A MAP KINASE |
| 4E5B | A: | STRUCTURE OF P38A MAP KINASE WITHOUT BOG |
| 4E6A | A: | P38A-PIA23 COMPLEX |
| 4E6C | A: | P38A-PERIFOSINE COMPLEX |
| 4E8A | A: | THE CRYSTAL STRUCTURE OF P38A MAP KINASE IN COMPLEX WITH PIA24 |
| 4EH2 | A: | HUMAN P38 MAP KINASE IN COMPLEX WITH NP-F1 AND RL87 |
| 4EH3 | A: | HUMAN P38 MAP KINASE IN COMPLEX WITH NP-F2 AND RL87 |
| 4EH4 | A: | HUMAN P38 MAP KINASE IN COMPLEX WITH NP-F3 AND RL87 |
| 4EH5 | A: | HUMAN P38 MAP KINASE IN COMPLEX WITH NP-F4 AND RL87 |
| 4EH6 | A: | HUMAN P38 MAP KINASE IN COMPLEX WITH NP-F5 AND RL87 |
| 4EH7 | A: | HUMAN P38 MAP KINASE IN COMPLEX WITH NP-F6 AND RL87 |
| 4EH8 | A: | HUMAN P38 MAP KINASE IN COMPLEX WITH NP-F7 AND RL87 |
| 4EH9 | A: | HUMAN P38 MAP KINASE IN COMPLEX WITH NP-F11 AND RL87 |
| 4EHV | A: | HUMAN P38 MAP KINASE IN COMPLEX WITH NP-F10 AND RL87 |
| 4EWQ | A: | HUMAN P38 ALPHA MAPK IN COMPLEX WITH A PYRIDAZINE BASED INHIBITOR |
| 4F9W | A: | HUMAN P38ALPHA MAPK IN COMPLEX WITH A NOVEL AND SELECTIVE SMALL MOLECULE INHIBITOR |
| 4F9Y | A: | HUMAN P38 ALPHA MAPK IN COMPLEX WITH A NOVEL AND SELECTIVE SMALL MOLECULE INHIBITOR |
| 4FA2 | A: | HUMAN P38 ALPHA MITOGEN-ACTIVATED KINASE IN COMPLEX WITH SB239063 |
| 4GEO | A: | P38A MAP KINASE DEF-POCKET PENTA MUTANT (M194A, L195A, H228A, I229A, Y258A) |
| 4KIN | A:; B:; C:; D: | CRYSTAL STRUCTURE OF MITOGEN-ACTIVATED PROTEIN KINASE 14 (P38-H5) COMPLEX WITH 5-(2-CHLOROPHENYL)-N-(5-(CYCLOPROPYLCARBAMOYL)-2-METHYLPHENYL)-2-THIOPHENECARBOXAMIDE |
| 4KIP | A:; B: | CRYSTAL STRUCTURE OF MITOGEN-ACTIVATED PROTEIN KINASE 14 (P38-H5) COMPLEX WITH 2-(2-CHLOROPHENYL)-N-(5-(CYCLOPROPYLCARBAMOYL)-2-METHYLPHENYL)-1,3-THIAZOLE-5-CARBOXAMIDE |
| 4KIQ | A:; B:; C:; D: | CRYSTAL STRUCTURE OF MITOGEN-ACTIVATED PROTEIN KINASE 14 (P38-H5) COMPLEX WITH ETHYL 6-((5-(CYCLOPROPYLCARBAMOYL)-2-METHYLPHENYL) CARBAMOYL)-1H-INDOLE-1-CARBOXYLATE |
| 4L8M | A: | HUMAN P38 MAP KINASE IN COMPLEX WITH A DIBENZOXEPINONE |
)
)